HUM vs JANX · P/E 39, rev $129.66B vs $1.49B cap
Humana Inc (HUM) versus Janux Therapeutics Inc (JANX) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Janux Therapeutics Inc (JANX) is a biotechnology company listed on US.
Latest reported HUM revenue for 2025-12-31 was $129.66B. Net income was $1.19B. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
JANX does not have a complete income-statement cache yet.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. JANX currently screens at market cap $1.49B.
Not investment advice. Open the HUM and JANX stock pages for the full models.
Not investment advice.